21161712|t|Different profiles of Alzheimer's disease cerebrospinal fluid biomarkers in controls and subjects with subjective memory complaints.
21161712|a|Cerebrospinal fluid (CSF) biomarkers, such as Abeta(42), total-tau and phosphorylated-tau(181) reflect neuropathological changes of Alzheimer's disease (AD). We studied these biomarkers in 24 controls and 19 subjects with subjective memory complaints, and we distinguished different CSF profiles: normal (group 1, 55.8%), only pathologic Abeta(42) (group 2, 27.9%), pathologic Abeta(42) plus pathologic total-tau and/or phosphorylated-tau(181) (group 3, 7%), and only pathologic total-tau and phosphorylated-tau(181) (group 4, 9.3%). Group 2 could represent an earlier phase of preclinical AD than group 3, and group 4 an unknown etiology.
21161712	22	41	Alzheimer's disease	Disease	MESH:D000544
21161712	114	131	memory complaints	Disease	MESH:D008569
21161712	179	188	Abeta(42)	Gene	351
21161712	196	199	tau	Gene	4137
21161712	219	222	tau	Gene	4137
21161712	265	284	Alzheimer's disease	Disease	MESH:D000544
21161712	286	288	AD	Disease	MESH:D000544
21161712	366	383	memory complaints	Disease	MESH:D008569
21161712	471	480	Abeta(42)	Gene	351
21161712	510	519	Abeta(42)	Gene	351
21161712	542	545	tau	Gene	4137
21161712	568	571	tau	Gene	4137
21161712	618	621	tau	Gene	4137
21161712	641	644	tau	Gene	4137
21161712	723	725	AD	Disease	MESH:D000544
21161712	Association	MESH:D008569	4137
21161712	Association	MESH:D000544	4137
21161712	Association	MESH:D008569	351
21161712	Association	MESH:D000544	351

